Edesa biotech stock price
Edesa Biotech to Develop Novel Treatment for Vitiligo in Collaboration with the National Research Council of Canada. TORONTO, ON / ACCESSWIRE / March 12, 2020 / Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company, today announced a collaborative research project with the National Research Council of Canada (NRC) to develop novel immunotherapies for vitiligo as well as other © 2019 Edesa Biotech, Inc. | All rights reserved